{
    "nctId": "NCT01152606",
    "briefTitle": "A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin",
    "officialTitle": "An Observational Study of Cardiac Events in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 3942,
    "primaryOutcomeMeasure": "Incidence of symptomatic congestive heart failure\\n(CHF) using New York Heart Association class II, III and IV, and cardiac death",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* All patients who are considered candidates to receive Herceptin for this indication\n\nExclusion Criteria:\n\n* Patients for whom Herceptin is contraindicated",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}